Pfizer in talks to transition EpiPen manufacturing into generics spinoff
Pfizer Inc is in talks to merge its contract manufacturer that produces Mylan's EpiPen emergency allergy treatment into the new generics business it has created by combining its older off-patent medicines unit with generic drugmaker Mylan NV , a Pfizer spokeswoman said.